nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant radiotherapy after radical prostatectomy: Evidence and analysis
|
Raldow, Ann |
|
2011 |
37 |
2 |
p. 89-96 8 p. |
artikel |
2 |
Advances in the systemic treatment of pancreatic neuroendocrine tumors
|
Yalcin, Suayib |
|
2011 |
37 |
2 |
p. 127-132 6 p. |
artikel |
3 |
5-Azacytidine in myelodysplastic syndromes: A clinical practice guideline
|
Buckstein, Rena |
|
2011 |
37 |
2 |
p. 160-167 8 p. |
artikel |
4 |
Cancer of unknown primary patients with midline nodal distribution: Midway between poor and favourable prognosis?
|
Pentheroudakis, George |
|
2011 |
37 |
2 |
p. 120-126 7 p. |
artikel |
5 |
Controversies in the management of adjuvant breast cancer with taxanes: Review of the current literature
|
Araque Arroyo, Patricia |
|
2011 |
37 |
2 |
p. 105-110 6 p. |
artikel |
6 |
Current and future adjuvant immunotherapies for melanoma: Blockade of cytotoxic T-lymphocyte antigen-4 as a novel approach
|
Agarwala, Sanjiv S. |
|
2011 |
37 |
2 |
p. 133-142 10 p. |
artikel |
7 |
Editorial Board
|
|
|
2011 |
37 |
2 |
p. IFC- 1 p. |
artikel |
8 |
Malignant pheochromocytomas and paragangliomas – The importance of a multidisciplinary approach
|
Andersen, Kim Francis |
|
2011 |
37 |
2 |
p. 111-119 9 p. |
artikel |
9 |
Second-line chemotherapy for small-Cell Lung Cancer (SCLC)
|
Kim, Young Hak |
|
2011 |
37 |
2 |
p. 143-150 8 p. |
artikel |
10 |
Use of molecular markers for predicting therapy response in cancer patients
|
Duffy, Michael J. |
|
2011 |
37 |
2 |
p. 151-159 9 p. |
artikel |
11 |
Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel
|
Ortmann, O. |
|
2011 |
37 |
2 |
p. 97-104 8 p. |
artikel |